title: A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial.
authors.affiliation: Division of Dermatology, University of Colorado Health Sciences Center, Denver 80262, USA.
authors.forename: P
authors.initials: P
authors.lastname: Walsh
authors.forename: R
authors.initials: R
authors.lastname: Gonzalez
authors.forename: S
authors.initials: S
authors.lastname: Dow
authors.forename: R
authors.initials: R
authors.lastname: Elmslie
authors.forename: T
authors.initials: T
authors.lastname: Potter
authors.forename: L M
authors.initials: LM
authors.lastname: Glode
authors.forename: A E
authors.initials: AE
authors.lastname: Baron
authors.forename: C
authors.initials: C
authors.lastname: Balmer
authors.forename: K
authors.initials: K
authors.lastname: Easterday
authors.forename: J
authors.initials: J
authors.lastname: Allen
authors.forename: P
authors.initials: P
authors.lastname: Rosse
mesh_terms: D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D004338:Drug Combinations; D015870:Gene Expression; D015316:Genetic Therapy; D007376:Interleukin-2 / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use*; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis; D010957:Plasmids; D018089:Superantigens / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use; D019444:Vaccines, DNA / Q000627:therapeutic use*
chemical_list: D004338:Drug Combinations; D007376:Interleukin-2; D018089:Superantigens; D019444:Vaccines, DNA